HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luke Elizabeth Hanna Selected Research

Monoclonal Antibodies

1/2018Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.
1/2018Cross Type Neutralizing Antibodies Detected in a Unique HIV-2 Infected Individual From India.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luke Elizabeth Hanna Research Topics

Disease

14Tuberculosis (Tuberculoses)
01/2022 - 12/2005
12Infections
07/2021 - 12/2005
9HIV Infections (HIV Infection)
10/2021 - 10/2012
3Inflammation (Inflammations)
11/2022 - 01/2019
3Pulmonary Tuberculosis
01/2018 - 12/2005
2Latent Tuberculosis
01/2022 - 01/2018
2COVID-19
07/2021 - 04/2021
2Disease Progression
01/2018 - 12/2005
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2021
1COVID-19 related pediatric multisystem inflammatory disease
04/2021
1Cytokine Release Syndrome
04/2021
1Coinfection
01/2020
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2019
1Cicatrix (Scar)
01/2018
1Extensively Drug-Resistant Tuberculosis
04/2016
1Lymph Node Tuberculosis (Scrofula)
09/2014
1Acquired Immunodeficiency Syndrome (AIDS)
10/2012
1Emerging Communicable Diseases (Emerging Infectious Diseases)
03/2012
1Malaria
07/2008
1Leprosy (Hansen's Disease)
07/2008
1Rheumatoid Arthritis
07/2008

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2016
6Pharmaceutical PreparationsIBA
04/2020 - 03/2012
5CytokinesIBA
04/2021 - 12/2005
3EpitopesIBA
11/2020 - 10/2012
3Isoniazid (Ftivazide)FDA LinkGeneric
04/2020 - 11/2016
3Rifampin (Rifampicin)FDA LinkGeneric
01/2020 - 01/2016
2LipidsIBA
01/2022 - 09/2019
2Lipopolysaccharide ReceptorsIBA
07/2021 - 01/2019
2Interleukin-10 (Interleukin 10)IBA
04/2021 - 01/2018
2Broadly Neutralizing AntibodiesIBA
01/2019 - 01/2018
2Monoclonal AntibodiesIBA
01/2018 - 01/2018
2Proteins (Proteins, Gene)FDA Link
10/2015 - 08/2012
1Antiviral Agents (Antivirals)IBA
10/2021
1Immunologic Factors (Immunomodulators)IBA
10/2021
1C-Reactive ProteinIBA
07/2021
1lipopolysaccharide-binding proteinIBA
07/2021
1Acute-Phase Proteins (Acute-Phase Protein)IBA
07/2021
1Amyloid (Amyloid Fibrils)IBA
07/2021
1HaptoglobinsIBA
07/2021
1LipopolysaccharidesIBA
07/2021
1Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA
07/2021
1SodiumIBA
04/2021
1Interleukin-2 (IL2)IBA
04/2021
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
04/2021
1Interleukin-6 (Interleukin 6)IBA
04/2021
1Granzymes (Granzyme)IBA
04/2021
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2021
1Interleukin-17 (Interleukin 17)IBA
04/2021
1Interleukin-15 (Interleukin 15)IBA
04/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2021
1Interleukin-33IBA
04/2021
1VaccinesIBA
12/2020
1Glycoproteins (Glycoprotein)IBA
11/2020
1Interleukin-8 (Interleukin 8)IBA
01/2020
19 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2020
1Amino AcidsFDA Link
09/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
09/2019
1Lipoproteins (Lipoprotein)IBA
09/2019
1Lamivudine (Epivir)FDA Link
01/2019
1Zidovudine (Retrovir)FDA LinkGeneric
01/2019
1Anti-HIV Agents (AIDS Drugs)IBA
01/2019
1MaravirocFDA Link
01/2018
1Tuberculin (PPD)IBA
01/2018
1Biological ProductsIBA
01/2018
1GoldIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1Neutralizing AntibodiesIBA
01/2018
1AIDS VaccinesIBA
10/2017
1PyrazinamideFDA LinkGeneric
01/2017
1tat Gene Products (tat Protein)IBA
01/2017
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2014
1HLA-B Antigens (HLA-B)IBA
10/2012
1HLA-A*02:01 antigenIBA
10/2012
1HLA-B*27:05 antigenIBA
10/2012
1Peptides (Polypeptides)IBA
10/2012
1AntigensIBA
08/2012
1AntibodiesIBA
07/2008
1HIV AntigensIBA
07/2008
1Chemokine CCL3IBA
12/2005
1Chemokine CCL4IBA
12/2005
1Chemokine ReceptorsIBA
12/2005
1ChemokinesIBA
12/2005
1Chemokine CCL5IBA
12/2005
1CC ChemokinesIBA
12/2005

Therapy/Procedure

3Therapeutics
10/2021 - 01/2018
1Highly Active Antiretroviral Therapy (HAART)
11/2022
1Art Therapy
09/2019